Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes (CONCEPTT): A Multicentre International Randomized Controlled Trial

Feig, D.S.; Donovan, L.E.; Corcoy, R.; Murphy, K.E.; Amiel, S.A. on behalf of the CONCEPTT Collaborative Group

doi: 10.1097/01.aoa.0000542359.79329.36
Mother, Fetus, Neonate

(Lancet 2017;390:2347–2359)

Pregnant women with type 1 diabetes are at increased risk of preeclampsia, cesarean delivery, congenital anomalies, and other adverse pregnancy outcomes. While optimal glycemic control during pregnancy can improve outcomes, it is difficult to accomplish due to the complexity of insulin dose adjustments, changes in insulin sensitivity, and variability of insulin absorption that all occur during pregnancy. Continuous glucose monitoring (CGM) has been successful at improving glycemic control in nonpregnant women but studies in pregnant women have had conflicting results. This study aimed to evaluate the effects of CGM in women with type 1 diabetes who were pregnant or planning to become pregnant.

Department of Medicine and Department of Obstetrics & Gynecology, Sinai Health System, Toronto, ON, Canada

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved